DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Tamura K, Tsurutani J, Takahashi S, Iwata H, Krop IE, Redfern C. et al.
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: A dose-expansion, phase 1 study.
Lancet Oncol 2019;
20: 816-26
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.